Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
2,990,172
-
Share change
-
+369,568
-
Total reported value
-
$12,711,000
-
Put/Call ratio
-
27%
-
Price per share
-
$4.25
-
Number of holders
-
28
-
Value change
-
+$1,643,747
-
Number of buys
-
12
-
Number of sells
-
13
Institutional Holders of ADAMIS PHARMACEUTICALS CORP - COM NEW (ADMP) as of Q1 2017
As of 31 Mar 2017,
ADAMIS PHARMACEUTICALS CORP - COM NEW (ADMP) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,990,172 shares.
The largest 10 holders included
Sio Capital Management, LLC, VANGUARD GROUP INC, PURA VIDA INVESTMENTS, LLC, BlackRock Inc., RAYMOND JAMES & ASSOCIATES, BARD ASSOCIATES INC, Leisure Capital Management, SUSQUEHANNA INTERNATIONAL GROUP, LLP, GEODE CAPITAL MANAGEMENT, LLC, and NORTHERN TRUST CORP.
This page lists
28
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.